Cargando…

Clinical effectiveness and safety of gemifloxacin versus cefpodoxime in acute exacerbation of chronic bronchitis: A randomized, controlled trial

OBJECTIVE: Acute exacerbation of chronic bronchitis (AECB) is a commonly encountered problem and those suspected to be due to bacterial infections require antibiotic therapy. This randomized, controlled trial was designed to evaluate the effectiveness and safety of gemifloxacin, a new fluoroquinolon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chatterjee, S., Biswas, T., Dutta, A., Sengupta, G., Mitra, A., Kundu, S.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062119/ https://www.ncbi.nlm.nih.gov/pubmed/21455420 http://dx.doi.org/10.4103/0253-7613.75667

Ejemplares similares

Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis
por: Jivcu, Cristian, et al.
Publicado: (2009)

Comparison of the effectiveness and safety of cefpodoxime and ciprofloxacin in acute exacerbation of chronic suppurative otitis media: A randomized, open-labeled, phase IV clinical trial
por: Ghosh, Arijit, et al.
Publicado: (2012)

Biphasic anaphylaxis to gemifloxacin
por: Yilmaz, İnsu, et al.
Publicado: (2012)

Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia
por: Amitabh, Vindu, et al.
Publicado: (2012)

Immunomodulatory activities of gemifloxacin in mice
por: Umair, Muhammad, et al.
Publicado: (2016)

Ion-pair spectrophotometric estimation of gemifloxacin
por: Sahu, Satyabrata, et al.
Publicado: (2012)

Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis and Acute Exacerbation of Chronic Bronchitis: A Phase Ⅱ, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
por: Lee, Su Won, et al.
Publicado: (2022)

Formulation and in vitro characterization of cefpodoxime proxetil gastroretentive microballoons
por: Sharma, AK., et al.
Publicado: (2011)

2262. Evaluation of Ceftriaxone Versus Cefazolin as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales Isolates
por: Lambert, Kaitlyn, et al.
Publicado: (2023)

Infection in acute exacerbations of chronic bronchitis: a clinical perspective
por: Read, R.C.
Publicado: (1999)

Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
por: Mansour-Ghanaei, Fariborz, et al.
Publicado: (2017)

Clinical Effects of Gemifloxacin on the Delay of Tuberculosis Treatment
por: Kim, Seo Yun, et al.
Publicado: (2013)

Efficacy of Cefpodoxime with Clavulanic Acid in the Treatment of Recurrent Pyoderma in Dogs
por: Sudhakara Reddy, B., et al.
Publicado: (2014)

Characterization of impurities in cefpodoxime proxetil using LC–MS(n)
por: Li, Jin, et al.
Publicado: (2014)

Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs
por: Gao, Yan-Yan, et al.
Publicado: (2022)

Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI)
por: Chuchalin, Alexander, et al.
Publicado: (2013)

Fluoroquinolone-Resistant Group B Streptococci in Acute Exacerbation of Chronic Bronchitis
por: Tazi, Asmaa, et al.
Publicado: (2008)

Antibacterials and Acute Exacerbation of Chronic Bronchitis: Issues for Formulary Decision Makers
por: Chock, Alan, et al.
Publicado: (2012)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations
por: Ball, Peter
Publicado: (1995)

Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin
por: Öncü, Serkan
Publicado: (2007)

Simultaneous RP-HPLC Estimation of Cefpodoxime Proxetil and Clavulanic Acid in Tablets
por: Malathi, S., et al.
Publicado: (2009)

Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones
por: Mensa, J., et al.
Publicado: (2006)

Viral and atypical pathogens as causes of type 1 acute exacerbations of chronic bronchitis
por: Roessingh, Peter H., et al.
Publicado: (2008)

A study of infective and other factors in exacerbations of chronic bronchitis
por: McHardy, Valentine U., et al.
Publicado: (1980)

Development and validation of spectrophotometric method of cefpodoxime proxetil using hydrotropic solubilizing agents
por: Asnani, Geet, et al.
Publicado: (2012)

Synthesis, characterization, molecular docking and biological evaluation of Schiff Base derivatives of cefpodoxime
por: Mahmood, Waqas, et al.
Publicado: (2022)

Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia
por: Zhanel, George G, et al.
Publicado: (2006)

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis
por: Blasi, Francesco, et al.
Publicado: (2007)

Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy
por: Saint, Sanjay, et al.
Publicado: (2001)

In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea.
por: Yong, Dong Eun, et al.
Publicado: (2002)

Anodic Voltammetric determination of gemifloxacin using screen-printed carbon electrode
por: Radi, Abd-Elgawad, et al.
Publicado: (2013)

The Effects of Moxifloxacin and Gemifloxacin on the ECG Morphology in Healthy Volunteers: A Phase 1 Randomized Clinical Trial
por: Ullah, Abid, et al.
Publicado: (2023)

Utility of NT-proBNP for Identifying LV Failure in Patients with Acute Exacerbation of Chronic Bronchitis
por: Wang, Qing-ping, et al.
Publicado: (2013)

The Economic Impact of Acute Exacerbations of Chronic Bronchitis in the United States and Canada: A Literature Review
por: Halpern, Michael T., et al.
Publicado: (2003)

Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication
por: Blasi, Francesco, et al.
Publicado: (2013)

Two Validated Spectrofluorometric Methods for Determination of Gemifloxacin Mesylate in Tablets and Human Plasma
por: Atia, Noha N., et al.
Publicado: (2013)

Design and evaluation of in situ gel eye drops containing nanoparticles of Gemifloxacin Mesylate
por: Kalaria, Vishwa J., et al.
Publicado: (2023)

Development and Validation of RP-HPLC Method for Simultaneous Estimation of Cefpodoxime Proxetil and Dicloxacillin Sodium in Tablets
por: Acharya, D. R., et al.
Publicado: (2013)

Insulinotropic Potential of Moxifloxacin and Gemifloxacin: An In Vivo Rabbits Model Study Followed by Randomized Phase I Clinical Trial
por: Ullah, Abid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0gse28cqcmojet06vqpm7tc1me